Drug Delivery Systems in Cancer Therapy -

Drug Delivery Systems in Cancer Therapy

Dennis M. Brown (Herausgeber)

Buch | Hardcover
390 Seiten
2003
Humana Press Inc. (Verlag)
978-0-89603-888-2 (ISBN)
235,39 inkl. MwSt
Leading experts survey the currently available technologies designed to improve the delivery of today's cancer chemotherapeutic agents. The authors review both the theoretical and practical considerations governing conventional and nonconventional methods of drug administration, and identify promising opportunities for product development. In their outline and discussion of the use of novel formulation technologies-including synthetic polymers and biomaterials for prolonged or sustained drug release to achieve potentially greater therapeutic effect-they profile those technologies that have resulted in a number of approved and late-stage clinical products.

I: Pharmacological Considerations for Drug Delivery Systems in Cancer Medicine.- 1 Systemically Administered Drugs.- 2 Regional Administration of Antineoplastic Drugs.- 3 Theoretical Analyses and Simulations of Anticancer Drug Delivery.- II: Technologies Available for Use in Cancer Drug Delivery Systems.- 4 Biopolymers for Parenteral Drug Delivery in Cancer Treatment.- 5 Hydrogels in Cancer Drug Delivery Systems.- 6 Microparticle Drug Delivery Systems.- 7 Polyethylene Glycol Conjugation of Protein and Small Molecule Drugs: Past, Present, and Future.- 8 Emulsions As Anticancer Delivery Systems.- III: Current Applications: Products Approved or in Advanced Clinical Development.- 9 Liposomal Drug Delivery Systems for Cancer Therapy.- 10 Gliadel®: A New Method for the Treatment of Malignant Brain Tumors.- 11 Intralesional Chemotherapy with Injectable Collagen Gel Formulations.- 12 Sustained-Release Drug Delivery with DepoFoam.- 13 Cancer Vaccines.- IV: Future Directions: Novel Cancer Drug Targets and Delivery Systems.- 14 Gene Therapy of Cancer.- 15 Progress in Antisense Technology.- 16 Tumor Vaccines.- 17 Diagnosis and Treatment of Human Disease Using Telomerase As a Novel Target.

Erscheint lt. Verlag 8.9.2003
Reihe/Serie Cancer Drug Discovery and Development
Zusatzinfo 57 Illustrations, black and white; X, 390 p. 57 illus.
Verlagsort Totowa, NJ
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Pharmazie PTA / PKA
ISBN-10 0-89603-888-2 / 0896038882
ISBN-13 978-0-89603-888-2 / 9780896038882
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99